DE69622652T2 - Substituierte indolymethylen-oxindol-analoge als tyrosin kinase inhibitoren - Google Patents

Substituierte indolymethylen-oxindol-analoge als tyrosin kinase inhibitoren

Info

Publication number
DE69622652T2
DE69622652T2 DE69622652T DE69622652T DE69622652T2 DE 69622652 T2 DE69622652 T2 DE 69622652T2 DE 69622652 T DE69622652 T DE 69622652T DE 69622652 T DE69622652 T DE 69622652T DE 69622652 T2 DE69622652 T2 DE 69622652T2
Authority
DE
Germany
Prior art keywords
indolymethylene
oxindol
analogs
substituted
kinase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69622652T
Other languages
English (en)
Other versions
DE69622652D1 (en
Inventor
Carlo Battistini
Dario Ballinari
Antonella Ermoli
Sergio Penco
Sergio Vioglio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of DE69622652D1 publication Critical patent/DE69622652D1/de
Publication of DE69622652T2 publication Critical patent/DE69622652T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69622652T 1995-04-07 1996-03-14 Substituierte indolymethylen-oxindol-analoge als tyrosin kinase inhibitoren Expired - Fee Related DE69622652T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9507298.9A GB9507298D0 (en) 1995-04-07 1995-04-07 Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
PCT/EP1996/001165 WO1996032380A1 (en) 1995-04-07 1996-03-14 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors

Publications (2)

Publication Number Publication Date
DE69622652D1 DE69622652D1 (en) 2002-09-05
DE69622652T2 true DE69622652T2 (de) 2003-03-06

Family

ID=10772745

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622652T Expired - Fee Related DE69622652T2 (de) 1995-04-07 1996-03-14 Substituierte indolymethylen-oxindol-analoge als tyrosin kinase inhibitoren

Country Status (7)

Country Link
US (1) US5849710A (de)
EP (1) EP0764152B1 (de)
JP (1) JPH10501821A (de)
DE (1) DE69622652T2 (de)
ES (1) ES2181875T3 (de)
GB (1) GB9507298D0 (de)
WO (1) WO1996032380A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147106A (en) 1997-08-20 2000-11-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6906093B2 (en) 1995-06-07 2005-06-14 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
CA2264220A1 (en) * 1996-08-23 1998-02-26 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
WO1998024432A2 (en) * 1996-12-05 1998-06-11 Sugen, Inc. Use of indolinone compounds as modulators of protein kinases
US6051597A (en) * 1997-06-13 2000-04-18 Merck & Co., Inc. Indolylquinones as antidiabetic agents
US20040067531A1 (en) * 1997-08-20 2004-04-08 Sugen, Inc. Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6133305A (en) * 1997-09-26 2000-10-17 Sugen, Inc. 3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
US6531502B1 (en) * 1998-01-21 2003-03-11 Sugen, Inc. 3-Methylidenyl-2-indolinone modulators of protein kinase
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
EP1117397A1 (de) * 1998-08-31 2001-07-25 Sugen, Inc. Geometrisch verhinderte 2-indolinonderivate als modulatoren der protein kinase aktivität
CN1158283C (zh) 1998-12-17 2004-07-21 霍夫曼-拉罗奇有限公司 作为蛋白激酶抑制剂的4-和5-吡嗪基羟吲哚
TR200101860T2 (tr) * 1998-12-17 2001-12-21 F.Hoffmann-La Roche Ag Sikline bağlı kinaz inhibitörleri olarak 4-alkenil (ve alkinil) oksidoller
KR20010087421A (ko) * 1998-12-17 2001-09-15 프리돌린 클라우스너, 롤란드 비. 보레르 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌
AU760039B2 (en) 1998-12-17 2003-05-08 F. Hoffmann-La Roche Ag 4-aryloxindoles as inhibitors of JNK protein kinases
US6153634A (en) 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
US6492398B1 (en) 1999-03-04 2002-12-10 Smithkline Beechman Corporation Thiazoloindolinone compounds
JP2002540096A (ja) * 1999-03-24 2002-11-26 スージェン・インコーポレーテッド キナーゼ阻害剤としてのインドリノン化合物
US6689806B1 (en) 1999-03-24 2004-02-10 Sugen, Inc. Indolinone compounds as kinase inhibitors
EP1175399B1 (de) * 1999-04-23 2009-03-11 Vertex Pharmaceuticals Incorporated Inhibitoren von c-jun n-terminal kinasen (jnk)
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
WO2001049287A1 (en) * 1999-12-30 2001-07-12 Sugen, Inc. 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
NZ520640A (en) * 2000-02-15 2005-04-29 Upjohn Co Pyrrole substituted 2-indolinone protein kinase inhibitors
US6620818B1 (en) 2000-03-01 2003-09-16 Smithkline Beecham Corporation Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
US7612065B2 (en) * 2000-04-21 2009-11-03 Vertex Pharmaceuticals Incorporated Inhibitors of c-JUN N-terminal kinases (JNK)
TWI270545B (en) 2000-05-24 2007-01-11 Sugen Inc Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
CA2410509A1 (en) * 2000-06-02 2001-12-13 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
US6504034B2 (en) 2001-01-23 2003-01-07 Hoffmann-La Roche Inc. Naphthostyrils
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
AU2002303892A1 (en) 2001-05-30 2002-12-09 Jingrong Cui 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
AR038957A1 (es) * 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
WO2003031438A1 (en) 2001-10-10 2003-04-17 Sugen, Inc. 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
JP2011506494A (ja) 2007-12-21 2011-03-03 ユニバーシティ・ヘルス・ネットワーク 癌の治療に有用なキナーゼ阻害剤としてのインダゾリル、ベンズイミダゾリル、ベンゾトリアゾリル置換インドルモン誘導体
EP2417127B1 (de) 2009-04-06 2014-02-26 University Health Network Kinasehemmer und verfahren zur krebsbehandlung damit
US20130029846A1 (en) 2010-03-29 2013-01-31 Basf Se Fungicidal Iminoderivatives
PT2556071T (pt) 2010-04-06 2016-11-22 Univ Health Network Inibidores de quinase e seus usos no tratamento de cancro
EP3057593B1 (de) 2013-10-18 2021-12-08 University Health Network Behandlung von bauchspeicheldrüsenkrebs
CN114601825B (zh) * 2022-02-18 2023-08-04 复旦大学附属中山医院 一种肠道菌群代谢物吲哚-3-甲醛在防治动脉粥样硬化中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
GB9115160D0 (en) * 1991-07-12 1991-08-28 Erba Carlo Spa Methylen-oxindole derivatives and process for their preparation
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors

Also Published As

Publication number Publication date
EP0764152A1 (de) 1997-03-26
US5849710A (en) 1998-12-15
EP0764152B1 (de) 2002-07-31
JPH10501821A (ja) 1998-02-17
ES2181875T3 (es) 2003-03-01
GB9507298D0 (en) 1995-05-31
DE69622652D1 (en) 2002-09-05
WO1996032380A1 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
DE69622652T2 (de) Substituierte indolymethylen-oxindol-analoge als tyrosin kinase inhibitoren
DE69627179D1 (de) Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren
LTPA2014028I1 (lt) Pakeistieji 3-cianochinolinai kaip proteintirozinkinazės inhibitoriai
ATE172199T1 (de) Proteinkinase-c-inhibitor
NO20002121D0 (no) Benzotiazol-protein-tyrosin-kinaseinhibitorer
ATE255575T1 (de) Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren
ID22982A (id) PIRAZOL-PIRAZOL TERSUBSTITUSI SEBAGAI INHIBITOR KINASE p38
PT1049695E (pt) Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase
ATE227283T1 (de) Kondensierte heterozyklische verbindungen als protein kinase inhibitoren
DE69724789D1 (de) Bicyclische heteroaromatic verbindungen als protein tyrosin kinase inhibitoren
DK1114817T3 (da) Substituerede benzylaminopiperidinforbindelser
NO974453L (no) Proteinkinase C-hemmere
LV12102A (lv) Rotamazes funkciju inhibitori
CY2008015I2 (el) Δικυκλικες ετepοαρωματικες ενωσεις σαν αναστολεις πρωτεϊνης κινασης τυροσινης
BR9612465A (pt) Compostos heterocíclicos
ATE236165T1 (de) Substituierte stickstoff enthaltende heterocyclen als p38 protein kinase inhibitoren
DE69631330D1 (de) C-4' modifizierte adenosinkinaseinhibitoren
DE69705112T2 (de) Coralynanaloge als topoisomerase inhibitoren
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
NO996572L (no) Nye substituerte imidazolforbindelser
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
ATE205836T1 (de) Bicyclische 4-aralkylaminopyrimidin-derivate als tyrosinkinase-inhibitoren
DE69531787D1 (de) INDENVERBINDUNGEN ALS sPLA2-INHIBITOREN
DE69938258D1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
DE69707098T2 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee